Inactive Instrument

Longevity Acquisition Corporation

Equities

LOAC

VGG563721320

Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2020

October 08, 2020 at 01:38 am IST

Longevity Acquisition Corporation announced earnings results for the second quarter ended August 31, 2020. For the second quarter, the company announced operating loss was USD 201,425 compared to USD 327,835 a year ago. Net loss was USD 200,138 compared to USD 118,757 a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.16 a year ago. For the half year, operating loss was USD 370,317 compared to USD 570,558 a year ago. Net loss was USD 323,977 compared to USD 109,186 a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.28 a year ago.

Latest news about Longevity Acquisition Corporation

4D Pharma : Lists on Nasdaq As Longevity Merger Closes, Raises $25 Million Via Share Placement	22/21/22	MT
4D pharma plc completed the acquisition of Longevity Acquisition Corporation from Whale Management Corporation and others.	22/21/22	CI
Longevity Acquisition Corporation(NasdaqCM:LOAC) dropped from NASDAQ Composite Index	19/21/19	CI
Longevity Acquisition : Shareholders Approve Merger With 4D Pharma	18/21/18	MT
4D Pharma : ADS Listing on Nasdaq Approved by US SEC	26/21/26	MT
Longevity Acquisition Corporation Announces 4D Pharma plc Update on Oncology Program	03/21/03	CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2020	13/21/13	CI
Longevity Acquisition : Regains Compliance With Nasdaq Listing Rules	11/20/11	MT
Longevity Acquisition : 4D Pharma Files for SEC Registration, in Process to Gain NASDAQ Listing	27/20/27	MT
Longevity Acquisition : Extends Proposed Deal Completion to May	21/20/21	MT
Longevity Acquisition Corporation Announces Management Changes	23/20/23	CI
Longevity Acquisition Corporation Announces Executive Changes	23/20/23	CI
Longevity Acquisition Corporation Announces Board Changes	23/20/23	CI
Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2020	08/20/08	CI
4D pharma plc signed a non-binding letter of intent to acquire Longevity Acquisition Corporation from Whale Management Corporation and others for $50.4 million.	07/20/07	CI
Longevity Acquisition Corporation Reports Earnings Results for the First Quarter Ended May 31, 2020	10/20/10	CI
Longevity Acquisition Corporation Reports Earnings Results for the Full Year Ended February 29, 2020	01/20/01	CI
Longevity Acquisition Corporation announced that it has received $0.4 million in funding from Whale Management Corporation	21/20/21	CI
Longevity Acquisition Corporation Announces Board Changes	25/20/25	CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2019	11/20/11	CI
Longevity Acquisition Corporation Announces Board Changes	06/19/06	CI
Longevity Acquisition Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2019	17/19/17	CI
Longevity Acquisition Corporation Reports Earnings Results for the First Quarter Ended May 31, 2019	16/19/16	CI
Longevity Acquisition Corporation Reports Earnings Results for the Full Year Ended February 28, 2019	30/19/30	CI
Longevity Acquisition Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2018	12/19/12	CI

Chart Longevity Acquisition Corporation

Duration

Period

More charts

Company Profile

Longevity Acquisition Corporation is a China-based blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation. The Company purchases all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities.

Sector

More about the company